Literature DB >> 26669439

mTOR inhibition activates overall protein degradation by the ubiquitin proteasome system as well as by autophagy.

Jinghui Zhao1, Bo Zhai1, Steven P Gygi1, Alfred Lewis Goldberg2.   

Abstract

Growth factors and nutrients enhance protein synthesis and suppress overall protein degradation by activating the protein kinase mammalian target of rapamycin (mTOR). Conversely, nutrient or serum deprivation inhibits mTOR and stimulates protein breakdown by inducing autophagy, which provides the starved cells with amino acids for protein synthesis and energy production. However, it is unclear whether proteolysis by the ubiquitin proteasome system (UPS), which catalyzes most protein degradation in mammalian cells, also increases when mTOR activity decreases. Here we show that inhibiting mTOR with rapamycin or Torin1 rapidly increases the degradation of long-lived cell proteins, but not short-lived ones, by stimulating proteolysis by proteasomes, in addition to autophagy. This enhanced proteasomal degradation required protein ubiquitination, and within 30 min after mTOR inhibition, the cellular content of K48-linked ubiquitinated proteins increased without any change in proteasome content or activity. This rapid increase in UPS-mediated proteolysis continued for many hours and resulted primarily from inhibition of mTORC1 (not mTORC2), but did not require new protein synthesis or key mTOR targets: S6Ks, 4E-BPs, or Ulks. These findings do not support the recent report that mTORC1 inhibition reduces proteolysis by suppressing proteasome expression [Zhang Y, et al. (2014) Nature 513(7518):440-443]. Several growth-related proteins were identified that were ubiquitinated and degraded more rapidly after mTOR inhibition, including HMG-CoA synthase, whose enhanced degradation probably limits cholesterol biosynthesis upon insulin deficiency. Thus, mTOR inhibition coordinately activates the UPS and autophagy, which provide essential amino acids and, together with the enhanced ubiquitination of anabolic proteins, help slow growth.

Entities:  

Keywords:  autophagy; mTOR; proteasome; ubiquitination

Mesh:

Substances:

Year:  2015        PMID: 26669439      PMCID: PMC4703015          DOI: 10.1073/pnas.1521919112

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  47 in total

Review 1.  Proteasome inhibitors: from research tools to drug candidates.

Authors:  A F Kisselev; A L Goldberg
Journal:  Chem Biol       Date:  2001-08

Review 2.  Functions of the proteasome: from protein degradation and immune surveillance to cancer therapy.

Authors:  A L Goldberg
Journal:  Biochem Soc Trans       Date:  2007-02       Impact factor: 5.407

3.  FoxO3 controls autophagy in skeletal muscle in vivo.

Authors:  Cristina Mammucari; Giulia Milan; Vanina Romanello; Eva Masiero; Ruediger Rudolf; Paola Del Piccolo; Steven J Burden; Raffaella Di Lisi; Claudia Sandri; Jinghui Zhao; Alfred L Goldberg; Stefano Schiaffino; Marco Sandri
Journal:  Cell Metab       Date:  2007-12       Impact factor: 27.287

4.  Efficient protection and isolation of ubiquitylated proteins using tandem ubiquitin-binding entities.

Authors:  Roland Hjerpe; Fabienne Aillet; Fernando Lopitz-Otsoa; Valerie Lang; Patrick England; Manuel S Rodriguez
Journal:  EMBO Rep       Date:  2009-10-02       Impact factor: 8.807

Review 5.  Regulation of the mevalonate pathway.

Authors:  J L Goldstein; M S Brown
Journal:  Nature       Date:  1990-02-01       Impact factor: 49.962

6.  Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules.

Authors:  K L Rock; C Gramm; L Rothstein; K Clark; R Stein; L Dick; D Hwang; A L Goldberg
Journal:  Cell       Date:  1994-09-09       Impact factor: 41.582

Review 7.  Intracellular protein degradation in mammalian and bacterial cells: Part 2.

Authors:  A L Goldberg; A C St John
Journal:  Annu Rev Biochem       Date:  1976       Impact factor: 23.643

8.  An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer.

Authors:  Teresa A Soucy; Peter G Smith; Michael A Milhollen; Allison J Berger; James M Gavin; Sharmila Adhikari; James E Brownell; Kristine E Burke; David P Cardin; Stephen Critchley; Courtney A Cullis; Amanda Doucette; James J Garnsey; Jeffrey L Gaulin; Rachel E Gershman; Anna R Lublinsky; Alice McDonald; Hirotake Mizutani; Usha Narayanan; Edward J Olhava; Stephane Peluso; Mansoureh Rezaei; Michael D Sintchak; Tina Talreja; Michael P Thomas; Tary Traore; Stepan Vyskocil; Gabriel S Weatherhead; Jie Yu; Julie Zhang; Lawrence R Dick; Christopher F Claiborne; Mark Rolfe; Joseph B Bolen; Steven P Langston
Journal:  Nature       Date:  2009-04-09       Impact factor: 49.962

9.  An ATP-competitive mammalian target of rapamycin inhibitor reveals rapamycin-resistant functions of mTORC1.

Authors:  Carson C Thoreen; Seong A Kang; Jae Won Chang; Qingsong Liu; Jianming Zhang; Yi Gao; Laurie J Reichling; Taebo Sim; David M Sabatini; Nathanael S Gray
Journal:  J Biol Chem       Date:  2009-01-15       Impact factor: 5.157

10.  FoxO3 coordinately activates protein degradation by the autophagic/lysosomal and proteasomal pathways in atrophying muscle cells.

Authors:  Jinghui Zhao; Jeffrey J Brault; Andreas Schild; Peirang Cao; Marco Sandri; Stefano Schiaffino; Stewart H Lecker; Alfred L Goldberg
Journal:  Cell Metab       Date:  2007-12       Impact factor: 27.287

View more
  155 in total

Review 1.  Insulin Regulation of Proteostasis and Clinical Implications.

Authors:  Haleigh A James; Brian T O'Neill; K Sreekumaran Nair
Journal:  Cell Metab       Date:  2017-07-14       Impact factor: 27.287

2.  Disentangling the aging gene expression network of termite queens.

Authors:  José Manuel Monroy Kuhn; Karen Meusemann; Judith Korb
Journal:  BMC Genomics       Date:  2021-05-11       Impact factor: 3.969

Review 3.  Adrenoceptor regulation of the mechanistic target of rapamycin in muscle and adipose tissue.

Authors:  Ling Yeong Chia; Bronwyn A Evans; Saori Mukaida; Tore Bengtsson; Dana S Hutchinson; Masaaki Sato
Journal:  Br J Pharmacol       Date:  2019-04-07       Impact factor: 8.739

4.  Regulation of Autophagic Flux by the 20S Proteasome.

Authors:  Evert Njomen; Jetze J Tepe
Journal:  Cell Chem Biol       Date:  2019-07-18       Impact factor: 8.116

5.  Therapeutic Benefit of Autophagy Modulation in Pompe Disease.

Authors:  Jeong-A Lim; Baodong Sun; Rosa Puertollano; Nina Raben
Journal:  Mol Ther       Date:  2018-05-03       Impact factor: 11.454

6.  Mechanisms Behind Resistance to PI3K Inhibitor Treatment Induced by the PIM Kinase.

Authors:  Jin H Song; Neha Singh; Libia A Luevano; Sathish K R Padi; Koichi Okumura; Virginie Olive; Stephen M Black; Noel A Warfel; David W Goodrich; Andrew S Kraft
Journal:  Mol Cancer Ther       Date:  2018-09-06       Impact factor: 6.261

7.  Ablation of elongation factor 2 kinase enhances heat-shock protein 90 chaperone expression and protects cells under proteotoxic stress.

Authors:  Jianling Xie; Petra Van Damme; Danielle Fang; Christopher G Proud
Journal:  J Biol Chem       Date:  2019-03-19       Impact factor: 5.157

8.  Focal Adhesion- and IGF1R-Dependent Survival and Migratory Pathways Mediate Tumor Resistance to mTORC1/2 Inhibition.

Authors:  Sang-Oh Yoon; Sejeong Shin; Florian A Karreth; Gwen R Buel; Mark P Jedrychowski; David R Plas; Shoukat Dedhar; Steven P Gygi; Philippe P Roux; Noah Dephoure; John Blenis
Journal:  Mol Cell       Date:  2017-07-27       Impact factor: 17.970

9.  Autophagy inhibition by biotin elicits endoplasmic reticulum stress to differentially regulate adipocyte lipid and protein synthesis.

Authors:  Senthilraja Selvam; Anand Ramaian Santhaseela; Dhasarathan Ganesan; Sudarshana Rajasekaran; Tamilselvan Jayavelu
Journal:  Cell Stress Chaperones       Date:  2019-01-15       Impact factor: 3.667

10.  Physiological and pathophysiological characteristics of ataxin-3 isoforms.

Authors:  Daniel Weishäupl; Juliane Schneider; Barbara Peixoto Pinheiro; Corinna Ruess; Sandra Maria Dold; Felix von Zweydorf; Christian Johannes Gloeckner; Jana Schmidt; Olaf Riess; Thorsten Schmidt
Journal:  J Biol Chem       Date:  2018-11-19       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.